Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bipolar Disorder01:30

Bipolar Disorder

537
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
537
Borderline Personality Disorder01:25

Borderline Personality Disorder

424
Borderline Personality Disorder is a complex and multifaceted mental health condition characterized by pervasive instability in interpersonal relationships, self-image, emotions, and impulse control. This instability manifests in extreme emotional reactions, fear of abandonment, and self-destructive behaviors. The disorder significantly impacts daily functioning, often leading to distress in both personal and professional domains.
Genetic and Environmental Contributions
Borderline Personality...
424
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

493
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
493
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

492
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
492
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

713
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
713
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

375
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
375

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychotic Features in Unipolar and Bipolar Depression: Commentary.

Acta psychiatrica Scandinavica·2026
Same author

Ratio of rates of suicide attempts to suicides in the general population and in mood disorder patients.

Journal of psychiatric research·2026
Same author

DNA methylation signatures associated with bipolar disorder in peripheral blood improve prediction models.

EBioMedicine·2026
Same author

Mood switching in 1629 antidepressant-treated bipolar disorder patients.

Journal of affective disorders·2026
Same author

Lithium effects on renal functioning: an expert opinion and management algorithm.

International journal of bipolar disorders·2026
Same author

Alcohol abuse by mood disorder patients.

Psychiatry research·2026

Related Experiment Video

Updated: Dec 29, 2025

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.1K

Suicidal Behavior Associated with Mixed Features in Major Mood Disorders.

Leonardo Tondo1, Gustavo H Vazquez2, Ross J Baldessarini3

  • 1International Consortium for Research on Mood & Psychotic Disorders, McLean Hospital, Belmont, MA, USA; Mailman Research Center 3, McLean Hospital, 115 Mill Street, Belmont, MA 02478-9106, USA; Department of Psychiatry, Harvard Medical School, Boston, MA, USA; Lucio Bini Mood Disorders Center, Cagliari, Italy.

The Psychiatric Clinics of North America
|February 4, 2020
PubMed
Summary

Mixed features in mood disorders significantly increase suicidal behavior risk. This review examines this association in major depressive and bipolar disorders, considering antidepressant side effects and alternative treatments.

Keywords:
AttemptDepressionIdeationLethalityMixed featuresRisk ratesSuicideTreatment

More Related Videos

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
06:55

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

23.2K
A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice
05:28

A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice

Published on: May 15, 2019

23.2K

Related Experiment Videos

Last Updated: Dec 29, 2025

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.1K
An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
06:55

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

23.2K
A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice
05:28

A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice

Published on: May 15, 2019

23.2K

Area of Science:

  • Psychiatry
  • Mood Disorders
  • Suicidology

Background:

  • Mixed features, encompassing symptoms of both depression and mania/hypomania, are increasingly recognized in major affective disorders.
  • These mixed states are linked to a substantially elevated risk of suicidal behaviors.

Purpose of the Study:

  • To review the association between suicidal behavior and mixed features in major depressive disorder and bipolar disorder.
  • To explore potential adverse effects of antidepressant treatments in this context.
  • To discuss alternative treatments for managing agitation and suicidal risk in patients with mixed features.

Main Methods:

  • Literature review of studies investigating mixed features and suicidal behavior.
  • Analysis of research on antidepressant adverse effects related to mixed states.
  • Examination of treatment strategies for agitation and suicidality in mood disorders.

Main Results:

  • Mixed features are a significant risk factor for suicidal behavior across depressive and bipolar disorders.
  • Antidepressant treatment may carry risks, particularly concerning agitation and increased suicidal ideation in some patients with mixed features.
  • Alternative or adjunctive treatments may be necessary to mitigate agitation and reduce suicidal risk.

Conclusions:

  • Recognizing and managing mixed features is crucial for assessing and reducing suicidal risk in major affective disorders.
  • Careful consideration of antidepressant use and exploration of alternative strategies are warranted for patients presenting with mixed features and suicidal ideation.
  • Further research is needed to optimize treatment protocols for mixed features to effectively manage agitation and prevent suicidal behaviors.